首页 | 本学科首页   官方微博 | 高级检索  
检索        

黄芪注射液抗心肌缺血再灌注损伤的临床研究
引用本文:周苏宁,邵伟,张文高.黄芪注射液抗心肌缺血再灌注损伤的临床研究[J].中国中西医结合急救杂志,2000,7(3):168-170.
作者姓名:周苏宁  邵伟  张文高
作者单位:山东中医药大学西医教学部!山东济南250014(周苏宁,张文高,鹿小燕),山东省千佛山医院麻醉科!山东济南250014(邵伟),山东省威海市建设集团职工医院!山东威海264200(于素勤)
基金项目:山东省自然科学基金!资助项目 ( Q99C0 3 )
摘    要:目的:探讨黄芪注射液防治体外循环心内直视手术中心肌缺血-再灌注损伤(MIRI)的作用机制。方法:将12例风湿性心肌病瓣膜置换术和先天性心脑病室内隔缺损修补术患者随机分为对照组和治疗组,每组6例。治疗组通过锁骨下静脉注黄芪注射液40g;对照组不加中药。检测2组在不同时间的心肌酶、氧自由基含量,一氧化氮(NO)和一氧化氮合酶(NOS)活性。结果:主动脉阻断致心肌缺血及心脏恢复灌注后心肌酶均呈上升趋势,

关 键 词:损伤  缺血-再灌注  黄芪注射液  心肌酶
修稿时间:2000-01-28

Clinical study of astragalus membranaceus injection on protecting myocardial ischemiareperfusion injury
ZHOU Suning,SHAO Wei,ZHANG Wengao,et al..Clinical study of astragalus membranaceus injection on protecting myocardial ischemiareperfusion injury[J].Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care,2000,7(3):168-170.
Authors:ZHOU Suning  SHAO Wei  ZHANG Wengao  
Institution:ZHOU Suning,SHAO Wei,ZHANG Wengao,et al. 1Shandong University TCM,Jinan Shandong 250014
Abstract:Objective:To investigate the mechanism of astragalus membranaceus injection on protecting myocardial ischemiareperfusion injury (MIRI) in open heart surgery under cardiopulmonary bypass.Methods:12 patients with either valvular heart disease or congenital ventricular septal defect were divided randomly into control group and treatment group,six cases in each group.Both groups were undergoing open heart surgery under cardiopulmonary bypass.The treatment group was injected 40 g astragalus membranaceus injection via subclavian,while the control group was not injected traditional Chinese medicine.Myocardial enzyme and oxygen free radical,the activity of nitric oxide(NO),nitric oxide synthase(NOS) in blood sample from via subclavian were measured in both groups at different time after injection.Results:The content of myocardial enzyme in the two groups both presented a tendency to ascend after aorta occluded and released.The content of creatine kinase(CK),MB isoenzyme of creatine kinase (CKMB) in treatment group at every time (except 10 minutes after aorta occluded) were significantly lower than those in control group( P <0 01 or P <0 05).At every time in both groups,the activity of serum superoxide dismutase(SOD) reduced and the content of malondialdehyde (MDA) increased,especially at the time after reperfusion 10 minutes.Both had obviously difference with those before operation (all P <0 05).Content of MDA in treatment group was significantly lower than that in control group at the time after reperfusion 10 minutes and 30 minutes ( P <0 01 or P <0 05).Activity of NO at the time after reperfusion 180 minutes in treatment group was significantly higher than that in control group ( P <0 05).Conclusions:Astragalus membranaceus injection can reduce the content of MDA and myocardial enzyme's release,improve the activity of NO,NOS and SOD after reperfusion,it protect MIRI effectively.
Keywords:ischemiareperfusion injury  astragalus membranaceus injection  myocardial enzyme  oxygen free radical  nitric oxide
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号